近日,来自安徽医科大学的研究者们在Br J Pharmacol杂志上发表了题为“The pathogenesis and development of targeted drugs in acute T lymphoblastic leukemia”的综述性文章,在这篇综述中,研究者旨在介绍T-ALL病因学中最新和最经典的信号通路,并阐明T-ALL治疗的潜在靶向药物。
Zhaoying Chen et al. The pathogenesis and development of targeted drugs in acute T lymphoblastic leukemia. Br J Pharmacol. 2023 Jan 9. doi: 10.1111/bph.16029.